Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone-modified low density lipoprotein

Journal of Lipid Research

Volumn 39, Issue 4, 1998, Pages 925-933

  Ferguson, Eric ^a   Parthasarathy, Sampath ^b   Joseph, Joy ^a   Kalyanaraman, B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apolipoprotein B 100; Atherosclerosis; Enzyme linked immunoadsorbent assay; Homocysteinemia; Lysyl residues; Measurement of plasma homocystamide protein adducts

Indexed keywords

APOLIPOPROTEIN B100; HOMOCYSTEINE THIOLACTONE; HOMOCYSTINE; LOW DENSITY LIPOPROTEIN; LYSINE; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYCLONAL ANTIBODY;

ACETYLATION; AMINO ACID BLOOD LEVEL; AMINOACIDEMIA; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DERIVATIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; LIPOPROTEIN METABOLISM; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RABBIT;

ANTIBODY SPECIFICITY; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; BINDING, COMPETITIVE; CYSTAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HOMOCYSTEINE; LIPOPROTEINS, LDL; LYSINE; VASCULAR DISEASES;

EID: 0031969378     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. McCully, K. S. 1996. Homocysteine and vascular disease. Nature Med. 2: 386-389.
2. McCully, K. S. 1993. Chemical pathology of homocysteine I. Atherogenesis. Ann. Clin. Lab. Med. 23: 477-493.
3. Ueland, P., and H. Refsum. 1989. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J. Lab. Clin. Med. 51: 159-170.
4. Benesch, R., and R. E. Benesch. 1956. Formation of peptide bonds by aminolysis of homocysteine thiolactone. J. Am. Chem. Soc. 78: 1597-1599.
5. Naruszewicz, M., E. Mirkiewicz, A. J. Olszewski, and K. S. McCully. 1994. Thiolation of low-density lipoprotein by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages. Nutr. Metab. Cardiovasc. Dis. 4: 70-77.
6. Yla-Herttuala, S., W. Palinski, M. Rosenfeld, S. Parthasarathy, T. Carew, S. Butler, J. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions in rabbits and man. J. Clin. Invest. 84: 1086-1095.
7. Steinbrecher, U. P., M. Fisher, J. L. Witztum, and L. K. Curtiss. 1984. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J. Lipid. Res. 25: 1109-1116.
8. Duddman, N. P. B., and D. E. L. Wilken. 1981. Homocysteine thiolactone and experimental homocyst(e)inemia. Biochem. Med. 27: 244-253.
9. Hatch, F. T., and R. S. Lees. 1968. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6: 2-68.
10. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
11. Hogg, N., V. M. Darley-Usmar, M. T. Wilson, and S. Moncada. 1993. The oxidation of α-tocophorol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett. 326: 199-203.
12. Steinbrecher, U. P., J. L. Witztum, S. Parthasarathy, and D. Steinberg. 1987. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 7: 135-143.
13. Swain, J. A., V. M. Darley-Usmar, and J. M. C. Gutteridge. 1994. Peroxynitrite releases copper from caeruloplasmin: implications for atherosclerosis. FEBS Lett. 342: 49-52.
14. Lim, Y. S., M. K. Cha, H. K. Kim, T. B. Uhm, J. W. Park, K. Kim, and I. H. Kim. 1993. Removals of hydrogen peroxide and hydroxyl radical by thiol-specific antioxidant protein as a possible role in vivo. Biochem. Biophys. Res. Commun. 192: 273-280.
15. Riddles, P. W., R. L. Blakely, and B. Zerner. 1979. Ellman's Reagent. 5,5,dithiobis (2-nitrobenzoic acid) - a reexamination. Anal. Biochem. 9: 75-81.
16. Ferguson, E., R. J. Singh, N. Hogg, and B. Kalyanaraman. 1997. The mechanism of apolipoprotein B-100 thiol depletion during oxidative modification of LDL. Arch. Biochem. Biophys. 341: 287-294.
17. Harlow, E., and D. Lane. 1988. Antibodies, a Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
18. Harker, L. A., R. Ross, S. J. Slichter, and C. R. Scott. 1976. Homocystine-induced arteriosclerosis. J. Clin. Invest. 58: 731-741.
19. Steinberg, D., S. Parthasarathy, T. Carew, J. Khoo, and J. Witztum. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
20. Parthasarathy, S. 1994. Modified Lipoproteins in the Pathogenesis of Atherosclerosis. Landes. Austin, TX.
21. Loscalzo, J. 1996. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 98: 5-7.
22. Starkebaum, G., and J. M. Harlan. 1986. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77: 1370-1376.
23. Wall, R. T., J. M. Harlan, L. A. Harker, and G. E. Striker. 1980. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb. Res. 18: 113-121.
24. Halvorsen, B., I. Brude, C. A. Drevon, J. Nysom, L. Ose, E. N. Christiansen, and M. S. Nenseter. 1996. Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein. J. Lipid. Res. 37: 1591-1600.
25. Lynch, S. M., and B. Frei. 1997. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim. Biophys. Acta. 1345: 215-221.
26. Santanam, N., and S. Parthasarathy. 1995. Cellular cysteine does not contribute to the initiation of LDL oxidation. J. Lipid. Res. 36: 2203-2211.
27. Hirano, K., T. Ogihara, M. Miki, H. Yasuda, H. Tamai, N. Kawamura, and M. Makoto. 1994. Homocysteine induces iron-catalyzed lipid peroxidation that is inhibited by alpha-tocopherol. Free Rad. Res 21: 267-276.
28. Heineke, J. W., H. Rosen, L. A. Suzuki, and A. Chait. 1987. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262: 10098-10103.
29. Sparrow, C. P., and J. Olszewski. 1993. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid. Res. 34: 1219-1228.
30. Jakubowski, H. 1997. Metabolism of homocysteine thiolactone in human cell cultures. J. Biol. Chem. 272: 1935-1942.
31. Olszewski, A. J., and K. S. McCully. 1991. Homocysteine content of lipoproteins in hypercholesterolemia. Atherosclerosis. 88: 61-68.
32. 2C leukemic lymphocytes. Biochimie. 68: 723-730.
33. McCully, K. S., and M. P. Vezeridis. 1988. Homocysteine thiolactone in atherosclerosis and cancer. Res. Commun. Chem. Pathol. Pharmacol. 59: 107-119.
34. McCully, K. S., and M. P. Vezeridis. 1989. Histopathological effects of homocysteine thiolactone on epithelial and stromal tissues. Exp. Mol. Pathol. 51: 159-170.
35. Uleand, P. M., H. Refsum, S. P. Stabler, M. R. Malinow, A. Andersson, and R. H. Allen. 1993. Total homocysteine in plasma or in serum: methods and clinical applications. Clin. Chem. 39: 1764-1779.
36. Malinow, M. R., G. Sexton, M. Averbuch, M. Grossman, D. Wilson, and B. Upson. 1990. Homocyst(e)inemia in daily practice: levels in coronary artery disease. Coron. Artery Dis. I: 215-220.